Cargando…

A prospect on the use of antiviral drugs to control local outbreaks of COVID-19

BACKGROUND: Current outbreaks of COVID-19 are threatening the health care systems of several countries around the world. Control measures, based on isolation, contact tracing, and quarantine, can decrease and delay the burden of the ongoing epidemic. With respect to the ongoing COVID-19 epidemic, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Torneri, Andrea, Libin, Pieter, Vanderlocht, Joris, Vandamme, Anne-Mieke, Neyts, Johan, Hens, Niel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315692/
https://www.ncbi.nlm.nih.gov/pubmed/32586336
http://dx.doi.org/10.1186/s12916-020-01636-4
_version_ 1783550307972677632
author Torneri, Andrea
Libin, Pieter
Vanderlocht, Joris
Vandamme, Anne-Mieke
Neyts, Johan
Hens, Niel
author_facet Torneri, Andrea
Libin, Pieter
Vanderlocht, Joris
Vandamme, Anne-Mieke
Neyts, Johan
Hens, Niel
author_sort Torneri, Andrea
collection PubMed
description BACKGROUND: Current outbreaks of COVID-19 are threatening the health care systems of several countries around the world. Control measures, based on isolation, contact tracing, and quarantine, can decrease and delay the burden of the ongoing epidemic. With respect to the ongoing COVID-19 epidemic, recent modeling work shows that these interventions may be inadequate to control local outbreaks, even when perfect isolation is assumed. The effect of infectiousness prior to symptom onset combined with asymptomatic infectees further complicates the use of contact tracing. We aim to study whether antivirals, which decrease the viral load and reduce infectiousness, could be integrated into control measures in order to augment the feasibility of controlling the epidemic. METHODS: Using a simulation-based model of viral transmission, we tested the efficacy of different intervention measures to control local COVID-19 outbreaks. For individuals that were identified through contact tracing, we evaluate two procedures: monitoring individuals for symptoms onset and testing of individuals. Additionally, we investigate the implementation of an antiviral compound combined with the contact tracing process. RESULTS: For an infectious disease in which asymptomatic and presymptomatic infections are plausible, an intervention measure based on contact tracing performs better when combined with testing instead of monitoring, provided that the test is able to detect infections during the incubation period. Antiviral drugs, in combination with contact tracing, quarantine, and isolation, result in a significant decrease of the final size and the peak incidence, and increase the probability that the outbreak will fade out. CONCLUSION: In all tested scenarios, the model highlights the benefits of control measures based on the testing of traced individuals. In addition, the administration of an antiviral drug, together with quarantine, isolation, and contact tracing, is shown to decrease the spread of the epidemic. This control measure could be an effective strategy to control local and re-emerging outbreaks of COVID-19.
format Online
Article
Text
id pubmed-7315692
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73156922020-06-25 A prospect on the use of antiviral drugs to control local outbreaks of COVID-19 Torneri, Andrea Libin, Pieter Vanderlocht, Joris Vandamme, Anne-Mieke Neyts, Johan Hens, Niel BMC Med Research Article BACKGROUND: Current outbreaks of COVID-19 are threatening the health care systems of several countries around the world. Control measures, based on isolation, contact tracing, and quarantine, can decrease and delay the burden of the ongoing epidemic. With respect to the ongoing COVID-19 epidemic, recent modeling work shows that these interventions may be inadequate to control local outbreaks, even when perfect isolation is assumed. The effect of infectiousness prior to symptom onset combined with asymptomatic infectees further complicates the use of contact tracing. We aim to study whether antivirals, which decrease the viral load and reduce infectiousness, could be integrated into control measures in order to augment the feasibility of controlling the epidemic. METHODS: Using a simulation-based model of viral transmission, we tested the efficacy of different intervention measures to control local COVID-19 outbreaks. For individuals that were identified through contact tracing, we evaluate two procedures: monitoring individuals for symptoms onset and testing of individuals. Additionally, we investigate the implementation of an antiviral compound combined with the contact tracing process. RESULTS: For an infectious disease in which asymptomatic and presymptomatic infections are plausible, an intervention measure based on contact tracing performs better when combined with testing instead of monitoring, provided that the test is able to detect infections during the incubation period. Antiviral drugs, in combination with contact tracing, quarantine, and isolation, result in a significant decrease of the final size and the peak incidence, and increase the probability that the outbreak will fade out. CONCLUSION: In all tested scenarios, the model highlights the benefits of control measures based on the testing of traced individuals. In addition, the administration of an antiviral drug, together with quarantine, isolation, and contact tracing, is shown to decrease the spread of the epidemic. This control measure could be an effective strategy to control local and re-emerging outbreaks of COVID-19. BioMed Central 2020-06-25 /pmc/articles/PMC7315692/ /pubmed/32586336 http://dx.doi.org/10.1186/s12916-020-01636-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Torneri, Andrea
Libin, Pieter
Vanderlocht, Joris
Vandamme, Anne-Mieke
Neyts, Johan
Hens, Niel
A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
title A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
title_full A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
title_fullStr A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
title_full_unstemmed A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
title_short A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
title_sort prospect on the use of antiviral drugs to control local outbreaks of covid-19
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315692/
https://www.ncbi.nlm.nih.gov/pubmed/32586336
http://dx.doi.org/10.1186/s12916-020-01636-4
work_keys_str_mv AT torneriandrea aprospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT libinpieter aprospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT vanderlochtjoris aprospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT vandammeannemieke aprospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT neytsjohan aprospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT hensniel aprospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT torneriandrea prospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT libinpieter prospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT vanderlochtjoris prospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT vandammeannemieke prospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT neytsjohan prospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19
AT hensniel prospectontheuseofantiviraldrugstocontrollocaloutbreaksofcovid19